Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia.
There is no current approved therapy for the ultimately lethal neuro- and cardio-degenerative disease Friedreich's ataxia (FA). Finding minimally-invasive molecular biomarkers of disease progression and drug effect could support smaller, shorter clinical trials. Since we and others have noted a...
Egile Nagusiak: | Genki Hayashi, Gino Cortopassi |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Public Library of Science (PLoS)
2016-01-01
|
Saila: | PLoS ONE |
Sarrera elektronikoa: | http://europepmc.org/articles/PMC4831832?pdf=render |
Antzeko izenburuak
-
Sexual dimorphism in a mouse model of Friedreich’s ataxia with severe cardiomyopathy
nork: Lili Salinas, et al.
Argitaratua: (2024-10-01) -
Potential biomarker identification for Friedreich's ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion.
nork: Marissa Z McMackin, et al.
Argitaratua: (2019-01-01) -
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.
nork: Mittal Jasoliya, et al.
Argitaratua: (2019-01-01) -
Genetics and Friedreich Ataxia
nork: J Gordon Millichap
Argitaratua: (2002-06-01) -
Genetics of Friedreich Ataxia
nork: J Gordon Millichap
Argitaratua: (1997-06-01)